Operating Lease, Payments in USD of Protara Therapeutics, Inc. from 2022 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Protara Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to Q1 2025.
  • Protara Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $332K, unchanged year-over-year.
  • Protara Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $1.33M, a 7.54% increase from 2023.
  • Protara Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.23M, a 7.01% decline from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

Protara Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $332K $0 0% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $332K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $332K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02

Protara Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.33M +$93K +7.54% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $1.23M -$93K -7.01% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $1.33M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.